ACET
Adicet Bio (ACET)
$03
About Adicet Bio (ACET)
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
Details
Daily high
$7.03
Daily low
$6.55
Price at open
$6.55
52 Week High
$17.44
52 Week Low
$6.41
Market cap
67.3M
Dividend yield
0.00%
Volume
226,294
Avg. volume
156,940
P/E ratio
-.35
Adicet Bio News
Details
Daily high
$7.03
Daily low
$6.55
Price at open
$6.55
52 Week High
$17.44
52 Week Low
$6.41
Market cap
67.3M
Dividend yield
0.00%
Volume
226,294
Avg. volume
156,940
P/E ratio
-.35